Goode news? . . .
Ralph W. Moss, Ph.D. Weekly CancerDecisions.com
Newsletter #375 01/18/09
CANCER DECISIONS FREE WEEKLY NEWSLETTER
We are gratified and excited by the announcement this week that the Food
and Drug Administration (FDA) has reached an agreement with the
Burzynski Research Institute, Inc., for the design of a phase III trial
of antineoplaston therapy for the treatment of diffuse intrinsic
brainstem glioma, a rare but highly aggressive form of childhood brain
cancer.
To read this week's newsletter, please click or go to:
http://www.cancerdecisions.com/011809.html
Having problems with message search?
Fill out this form to ensure your group is one of the first to be migrated to the new message search system.
Offline 
Send Email